Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers

Conclusions CW002 has predictable pharmacokinetics and is likely to have a rapid onset with an intermediate duration of action at 3 × ED95. This model provides information to inform critical decisions (e.g., dose, study design) for continued development of CW002.

http://anesthesiology.pubs.asahq.org/article.aspx?articleid=2674196

Source: Anesthesiology - May 15, 2018 Category: Anesthesiology Source Type: research